Bob Weijs1, Ione Limantoro1, Tammo Delhaas2, Cees B de Vos1, Yuri Blaauw3, Richard P M Houben4, Sander Verheule2, Ronny Pisters5, Harry J G M Crijns1. 1. Department of Cardiology, Maastricht University Medical Centre and Cardiovascular Research Institute Maastricht, Maastricht, the Netherlands. 2. Department of Physiology, Maastricht University Medical Centre and Cardiovascular Research Institute Maastricht, Maastricht, the Netherlands. 3. Department of Cardiology, University Medical Center Groningen, Groningen, the Netherlands. 4. Medtronic Bakken Research Center Maastricht, Maastricht, the Netherlands. 5. Department of Cardiology, Rijnstate Hospital Arnhem, Arnhem, the Netherlands.
Abstract
BACKGROUND: Many recurrences occur after electrical cardioversion (ECV) of atrial fibrillation (AF). Assessment of extent of remodeling and continuous prolonged rhythm monitoring might reveal actionable recurrence mechanisms. HYPOTHESIS: After ECV of AF specific patterns of arrhythmia recurrence can be distinguished. METHODS: All patients who underwent successful ECV due to persistent AF were included. Tissue velocity echocardiography during AF was performed before ECV to study atrial fibrillatory cycle length and fibrillatory velocity. After ECV, the heart rhythm of all patients was monitored 3 times daily during 4 weeks, and timing of recurrence was noted. RESULTS: In total, 50 patients (68% male) were included; mean age was 68 ± 9 years. Median duration of the current AF episode was 102 (range, 74-152) days. Twenty-one (42%) patients showed recurrence of persistent AF. No recurrences occurred during the first 24 hours. There were no differences in clinical characteristics between patients with or without recurrence of AF. However, patients with early recurrence of AF had significantly higher precardioversion wall-motion velocity compared with patients who remained in sinus rhythm (2.8 [1.6-3.6] vs 1.4 [0.9-3.3] cm/s; P = 0.017), whereas atrial fibrillatory cycle length did not differ. CONCLUSIONS: In this study on 50 patients successfully cardioverted for persistent AF, there was a relapse gap of ≥24 hours. This phenomenon has not been well appreciated before and offers an AF-free window of opportunity for electrocardiographically triggered cardiac imaging or complex electrophysiological procedures. Echocardiographic tissue velocity imaging may visualize atrial remodeling relevant to AF recurrence.
BACKGROUND: Many recurrences occur after electrical cardioversion (ECV) of atrial fibrillation (AF). Assessment of extent of remodeling and continuous prolonged rhythm monitoring might reveal actionable recurrence mechanisms. HYPOTHESIS: After ECV of AF specific patterns of arrhythmia recurrence can be distinguished. METHODS: All patients who underwent successful ECV due to persistent AF were included. Tissue velocity echocardiography during AF was performed before ECV to study atrial fibrillatory cycle length and fibrillatory velocity. After ECV, the heart rhythm of all patients was monitored 3 times daily during 4 weeks, and timing of recurrence was noted. RESULTS: In total, 50 patients (68% male) were included; mean age was 68 ± 9 years. Median duration of the current AF episode was 102 (range, 74-152) days. Twenty-one (42%) patients showed recurrence of persistent AF. No recurrences occurred during the first 24 hours. There were no differences in clinical characteristics between patients with or without recurrence of AF. However, patients with early recurrence of AF had significantly higher precardioversion wall-motion velocity compared with patients who remained in sinus rhythm (2.8 [1.6-3.6] vs 1.4 [0.9-3.3] cm/s; P = 0.017), whereas atrial fibrillatory cycle length did not differ. CONCLUSIONS: In this study on 50 patients successfully cardioverted for persistent AF, there was a relapse gap of ≥24 hours. This phenomenon has not been well appreciated before and offers an AF-free window of opportunity for electrocardiographically triggered cardiac imaging or complex electrophysiological procedures. Echocardiographic tissue velocity imaging may visualize atrial remodeling relevant to AF recurrence.
Authors: R G Tieleman; I C Van Gelder; H J Crijns; P J De Kam; M P Van Den Berg; J Haaksma; H J Van Der Woude; M A Allessie Journal: J Am Coll Cardiol Date: 1998-01 Impact factor: 24.094
Authors: Harry J G M Crijns; Bob Weijs; Anna-Meagan Fairley; Thorsten Lewalter; Aldo P Maggioni; Alfonso Martín; Piotr Ponikowski; Mårten Rosenqvist; Prashanthan Sanders; Mauricio Scanavacca; Lori D Bash; François Chazelle; Alexandra Bernhardt; Anselm K Gitt; Gregory Y H Lip; Jean-Yves Le Heuzey Journal: Int J Cardiol Date: 2014-01-25 Impact factor: 4.164
Authors: David Schwartzman; Shailesh Kumar Musley; Charles Swerdlow; Robert H Hoyt; Eduardo N Warman Journal: J Am Coll Cardiol Date: 2002-07-03 Impact factor: 24.094
Authors: Ione Limantoro; Cees B de Vos; Tammo Delhaas; Bob Weijs; Yuri Blaauw; Ulrich Schotten; Bas Kietselaer; Ron Pisters; Harry J G M Crijns Journal: Europace Date: 2014-03-25 Impact factor: 5.214
Authors: Bob Weijs; Ione Limantoro; Tammo Delhaas; Cees B de Vos; Yuri Blaauw; Richard P M Houben; Sander Verheule; Ronny Pisters; Harry J G M Crijns Journal: Clin Cardiol Date: 2018-03-22 Impact factor: 2.882
Authors: Astrid N L Hermans; Nikki A H A Pluymaekers; Theo A R Lankveld; Manouk J W van Mourik; Stef Zeemering; Trang Dinh; Dennis W den Uijl; Justin G L M Luermans; Kevin Vernooy; Harry J G M Crijns; Ulrich Schotten; Dominik Linz Journal: Int J Cardiol Heart Vasc Date: 2021-09-15
Authors: Axel Brandes; Harry J G M Crijns; Michiel Rienstra; Paulus Kirchhof; Erik L Grove; Kenneth Bruun Pedersen; Isabelle C Van Gelder Journal: Europace Date: 2020-08-01 Impact factor: 5.214